Endo International plc Pharmaceutical preparations

Stock predictor AI models:
$ 5.39 Last close price
at 27-nov-2020

ENDP

Model's trade recommendations No return for period yet

$1.26B Market Cap

β 0.34  

ENDP

Model (following trade recommendations)

ENDP

Underlying stock

S&P 500

Index
Return for period
17.94%
1.78%
52wk return
6.10%
16.82%
52wk Range
2.28—6.60
2000.54—2399.63
  • HOLD Analysts consensus recommendation

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.

Industry sector: Medical

Sector classification: Pharmaceutical preparations

Float 223M
P/E 1.47
Shares Outstanding 224M
% Held by Insiders 0.50%
% Held by Institutions 93.95%
EPS (last reported FY) $3.84
EPS (last reported Q) $0.77
EPS, estimated (last reported Q) $0.62
Total revenues $3 B
Net income $-2 B